
MiNK Therapeutics: A Bargain For Potential Cell Therapies (NASDAQ:INKT)
Design Cells/iStock via Getty Images MiNK Therapeutics (NASDAQ:INKT) is a clinical-stage biotechnology company specializing in engineering immune system cells to provide therapies for cancers and other diseases. Initial enthusiasm for the stock, which had its […]